Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel
A Volpe, M Silferi, A Mauri, P Deiana, S Angioni… - European Journal of …, 1994 - Elsevier
A new biphasic oral contraceptive (OC) containing ethinylestradiol and desogestrel (DGS) in
both phases of the cycle (7 days 40 25 μg+ 15 days 30 125 μg) was tested for its reliability …
both phases of the cycle (7 days 40 25 μg+ 15 days 30 125 μg) was tested for its reliability …
Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate
M Vartiainen, H De Gezelle… - The European Journal of …, 2001 - Taylor & Francis
Objective: To investigate the effect of a combiphasic oral contraceptive containing
ethinylestradiol and desogestrel (combiphasic EE/DSG) on acne, compared with a …
ethinylestradiol and desogestrel (combiphasic EE/DSG) on acne, compared with a …
Desogestrel: using a selective progestogen in a combined oral contraceptive
M Op ten Berg - Advances in contraception, 1991 - Springer
Desogestrel is the most selective progestogen used in oral contraceptives (OCs). The
clinical characteristics of the monophasic combined OC containing 150 μg desogestrel and …
clinical characteristics of the monophasic combined OC containing 150 μg desogestrel and …
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
CM Coenen, CM Thomas, GF Borm… - International Journal of …, 1995 - europepmc.org
Changes in endogenous androgen metabolism were compared in healthy women taking
one of four low-dose modern oral contraceptives (OCs). One hundred women were …
one of four low-dose modern oral contraceptives (OCs). One hundred women were …
Clinical and metabolic features of desogestrel: A new oral contraceptive preparation
DF Archer - American journal of obstetrics and gynecology, 1994 - Elsevier
Desogestrel is a highly selective gonane progestin. A monophasic formulation containing
150 of μg desogestrel and 30 μg of ethinyl estradiol has recently been approved as an oral …
150 of μg desogestrel and 30 μg of ethinyl estradiol has recently been approved as an oral …
Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone
N Van der Vange, MA Blankenstein, HJ Kloosterboer… - Contraception, 1990 - Elsevier
The effect of seven low-dose oral contraceptive preparations on sex hormone binding
globulin (SHBG), corticol binding globulin (CBG), total and absolute free testosterone were …
globulin (SHBG), corticol binding globulin (CBG), total and absolute free testosterone were …
Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris …
PG Sator, JB Schmidt, H Hönigsmann - Dermatology, 2003 - karger.com
Abstract Background and Objective: The aim of this study was to evaluate the efficacy of a
triphasic combination oral contraceptive (OC) containing norgestimate and ethinyl estradiol …
triphasic combination oral contraceptive (OC) containing norgestimate and ethinyl estradiol …
Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol
S Stone - International journal of fertility and menopausal …, 1993 - pubmed.ncbi.nlm.nih.gov
PIP: A monophasic oral contraceptive (OC) containing 30 mcg ethinyl estradiol and 150 mcg
desogestrel is the most commonly used OC in Europe. Desogestrel alone inhibits ovulation …
desogestrel is the most commonly used OC in Europe. Desogestrel alone inhibits ovulation …
Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d, l-norgestrel
A LEMAY, SD DEWAILLY, R GRENIER… - The Journal of Clinical …, 1990 - academic.oup.com
The effect of a low dose triphasic oral contraceptive (OC) was evaluated during a 6-month
treatment period in 41 patients (mean age, 25.4±0.7 yr) who had grade I-IV postpubertal …
treatment period in 41 patients (mean age, 25.4±0.7 yr) who had grade I-IV postpubertal …
Effect of low-dose oral contraceptives on androgenic markers and acne
IH Thorneycroft, FZ Stanczyk, KD Bradshaw… - Contraception, 1999 - Elsevier
Oral contraceptives (OC) suppress excess androgen production; however, different
progestins in combination with low-dose estrogens produce divergent effects on sex …
progestins in combination with low-dose estrogens produce divergent effects on sex …